BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $137,638 | -0.5% | 3,647 | +20.1% | 0.01% | 0.0% |
| Q2 2023 | $138,366 | -91.4% | 3,037 | -92.3% | 0.01% | -54.5% |
| Q1 2023 | $1,600,092 | -37.4% | 39,450 | -21.3% | 0.02% | -42.1% |
| Q4 2022 | $2,554,107 | -99.9% | 50,110 | +2.3% | 0.04% | -5.0% |
| Q3 2022 | $2,637,848,000 | -1.6% | 48,976 | +17.4% | 0.04% | +14.3% |
| Q2 2022 | $2,679,419,000 | -16.5% | 41,716 | +0.8% | 0.04% | -5.4% |
| Q1 2022 | $3,209,613,000 | -10.1% | 41,393 | -0.5% | 0.04% | 0.0% |
| Q4 2021 | $3,570,687,000 | +11.5% | 41,597 | +4.5% | 0.04% | +8.8% |
| Q3 2021 | $3,202,160,000 | -69.2% | 39,813 | -69.2% | 0.03% | -67.3% |
| Q2 2021 | $10,393,919,000 | -21.3% | 129,117 | -17.5% | 0.10% | -28.8% |
| Q1 2021 | $13,202,920,000 | +5.2% | 156,544 | +0.1% | 0.15% | +2.8% |
| Q4 2020 | $12,553,066,000 | +5.6% | 156,444 | +5.8% | 0.14% | -11.8% |
| Q3 2020 | $11,887,684,000 | -34.2% | 147,820 | -29.6% | 0.16% | -40.1% |
| Q2 2020 | $18,077,040,000 | +0.2% | 209,954 | -5.5% | 0.27% | -13.5% |
| Q1 2020 | $18,040,338,000 | -16.9% | 222,199 | -14.5% | 0.31% | +11.1% |
| Q4 2019 | $21,719,795,000 | +0.7% | 259,744 | +5.3% | 0.28% | -6.7% |
| Q3 2019 | $21,574,212,000 | +2.7% | 246,647 | -3.8% | 0.30% | -6.5% |
| Q2 2019 | $21,000,634,000 | +5.8% | 256,418 | +5.0% | 0.32% | -2.1% |
| Q1 2019 | $19,851,186,000 | +24.4% | 244,142 | +0.7% | 0.33% | +20.6% |
| Q4 2018 | $15,962,139,000 | -14.0% | 242,512 | +0.7% | 0.27% | -14.5% |
| Q3 2018 | $18,567,358,000 | +19.3% | 240,853 | +14.2% | 0.32% | +6.4% |
| Q2 2018 | $15,569,608,000 | +4.7% | 210,856 | -7.8% | 0.30% | +0.7% |
| Q1 2018 | $14,870,225,000 | +14.7% | 228,632 | +14.0% | 0.30% | +0.7% |
| Q4 2017 | $12,961,936,000 | -5.8% | 200,525 | -8.6% | 0.30% | -2.6% |
| Q3 2017 | $13,762,645,000 | +4.8% | 219,325 | +1.1% | 0.30% | +4.8% |
| Q2 2017 | $13,136,151,000 | -29.1% | 216,983 | -39.3% | 0.29% | +95.3% |
| Q1 2017 | $18,528,229,000 | -5.8% | 357,274 | -1.2% | 0.15% | -20.0% |
| Q4 2016 | $19,669,186,000 | +124.1% | 361,604 | +96.1% | 0.18% | +94.7% |
| Q3 2016 | $8,775,344,000 | -1.6% | 184,356 | -8.4% | 0.10% | -3.1% |
| Q2 2016 | $8,921,120,000 | +7.4% | 201,320 | -0.5% | 0.10% | +8.9% |
| Q1 2016 | $8,308,964,000 | +459.7% | 202,263 | +419.8% | 0.09% | +462.5% |
| Q4 2015 | $1,484,417,000 | -74.4% | 38,910 | -78.7% | 0.02% | -75.0% |
| Q3 2015 | $5,798,911,000 | -64.8% | 182,518 | -22.5% | 0.06% | -60.2% |
| Q2 2015 | $16,460,262,000 | -32.2% | 235,382 | -32.0% | 0.16% | -23.7% |
| Q1 2015 | $24,292,850,000 | -5.2% | 346,211 | -1.0% | 0.21% | -13.5% |
| Q4 2014 | $25,618,153,000 | -1.6% | 349,545 | -3.7% | 0.24% | -3.9% |
| Q3 2014 | $26,038,229,000 | -2.1% | 362,801 | -1.4% | 0.25% | -0.8% |
| Q2 2014 | $26,595,339,000 | +2.1% | 367,847 | +3.9% | 0.26% | -7.6% |
| Q1 2014 | $26,054,751,000 | +7.8% | 354,101 | +1.9% | 0.28% | 0.0% |
| Q4 2013 | $24,179,095,000 | +16.9% | 347,651 | +10.4% | 0.28% | +6.9% |
| Q3 2013 | $20,678,734,000 | +9.1% | 314,798 | +18.6% | 0.26% | -10.7% |
| Q2 2013 | $18,961,639,000 | – | 265,525 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |